Last updated at 08 Mar 2024 12:00 PM
Director
DIN: 07494384
Samiksha Samir Gaikwad is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at SAMEEKSHA PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07494384.Samiksha Samir Gaikwad is currently involved in 2 different roles. Their most recent position is with ZYREX HEALTHCARE PRIVATE LIMITED as a Director. The first company Samiksha Samir Gaikwad was appointed to as a director was SAMEEKSHA PHARMACEUTICALS PRIVATE LIMITED. Samiksha Samir Gaikwad is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Samiksha Samir Gaikwad is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at SAMEEKSHA PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07494384.Samiksha Samir Gaikwad is currently involved in 2 different roles. Their most recent position is with ZYREX HEALTHCARE PRIVATE LIMITED as a Director. The first company Samiksha Samir Gaikwad was appointed to as a director was SAMEEKSHA PHARMACEUTICALS PRIVATE LIMITED. Samiksha Samir Gaikwad is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 11m 1 Year Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SAMEEKSHA PHARMACEUTICALS PRIVATE LIMITED | Director | 01-May-2016 |
| SAMEEKSHA PHARMACEUTICALS PRIVATE LIMITED | Individual Promoter | 01-May-2016 |
| ZYREX HEALTHCARE PRIVATE LIMITED | Director | 10-Aug-2022 |